RE: CLN's outstanding as at 3/7/1713 Nov 2018 10:48
Further to the Company's announcement on 16 July 2018, Flying Brands is pleased to announce that its prospectus ("Prospectus") has been approved by the Financial Conduct Authority. The Prospectus is in connection with the issue of 6,200,000 Ordinary Shares to the sellers of Imaging Biometrics LLC ("IB") to satisfy the remaining consideration shares due under the Share Purchase Agreement between IB and the Company; (2) the conversion of £195,050 11 March 2015 convertible loan notes into 21,787,061 Ordinary Shares; and (3) a fundraise of £500,000 (before expenses) pursuant to a placing of 20,000,000 Ordinary Shares at a price of 2.5 pence per placing share.